发明名称 |
Pharmaceutical compositions |
摘要 |
Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic. |
申请公布号 |
US9498444(B2) |
申请公布日期 |
2016.11.22 |
申请号 |
US201514789886 |
申请日期 |
2015.07.01 |
申请人 |
LOCL PHARMA, INC. |
发明人 |
Bosse Paul;Ameling John;Schachtel Bernard;Takigiku Ray |
分类号 |
A61K9/24;A61K9/20;A61K31/165;A61K31/167;A61K31/437;A61K31/485;A61K31/5415;A61K9/48;A61K31/24;A61K31/515;A61K45/06;A61K31/522;A61K31/403;A61K31/404;A61K31/4196;A61K31/422;A61K31/454;A61K47/36;A61K9/00;A61K9/16 |
主分类号 |
A61K9/24 |
代理机构 |
Wilson, Sonsini, Goodrich & Rosati |
代理人 |
Wilson, Sonsini, Goodrich & Rosati |
主权项 |
1. A method for treating pain, and reducing or preventing opioid-induced nausea or vomiting, the method comprising administering a solid oral pharmaceutical composition to a subject in need thereof, wherein the solid oral pharmaceutical composition comprises:
an immediate-release matrix comprising an antiemetic; and a controlled-release matrix comprising an opioid analgesic and a non-opioid analgesic, wherein the solid oral pharmaceutical composition demonstrates the following dissolution profile: wherein about 90% of the antiemetic is released in about 1 minute to about 20 minutes following contact of the solid oral pharmaceutical composition with a dissolution fluid as measured by a USP Apparatus 2 (Paddle Apparatus), wherein about 30% to about 60% of the opioid analgesic is released in about 5 to 10 minutes following contact of the solid oral pharmaceutical composition with a dissolution fluid as measured by a USP Apparatus 2 (Paddle Apparatus), and wherein about 100% of the opioid analgesic is released in about 60 minutes following contact of the solid oral pharmaceutical composition with a dissolution fluid as measured by a USP Apparatus 2 (Paddle Apparatus), and wherein the solid oral pharmaceutical composition provides an effective amount of the opioid analgesic and the non-opioid analgesic to treat pain, and wherein the solid oral pharmaceutical composition provides an effective amount of the antiemetic to reduce or prevent nausea associated with the opioid analgesic or vomiting associated with the opioid analgesic. |
地址 |
Las Vegas NV US |